• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139501
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 02/25/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
An analysis of the product could not be performed since a physical sample was not received for evaluation.A manufacturing record evaluation was performed for the finished device number lot 31469395l and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent a cardiac ablation with a qdot micro¿ catheter and the patient experienced cardiac tamponade that required pericardiocentesis.After the procedure completion, the cardiac tamponade was found when the patient was in the hospital ward.Blood pressure decrease was confirmed in the hospital ward.Thoracic echography revealed pericardial effusion, and drainage was performed.After the drainage, the patient¿s conditions were stabilized.The patient was under observation.Patient fully recovered and required extended hospitalization for observation.The physician's opinion on the relationship between the event and the product was that the catheter might have been pressed strongly; however, the physician did not consider that the event occurred during the ablation.No abnormalities were observed prior to or during use of the product.No evidence of steam pop.No error messages observed on biosense webster equipment during the procedure.The procedural act (activated clotting time) was over 300.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO¿ CATHETER
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key21657887
Report Number2029046-2025-00860
Device Sequence Number15510290
Product Code OAE
UDI-Device Identifier10846835016710
UDI-Public(01)10846835016710(11)241007(17)271006(10)31469395L
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P210027
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD139501
Device Lot Number31469395L
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/25/2025
Initial Report FDA Received Date03/20/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NGEN GENERATOR PUMP; NGEN PUMP; RF NEEDLE (BSJ)
Outcome Attributed to Adverse Event Required Intervention; Hospitalization; Life Threatening;
Patient SexFemale
-
-